CAIRO: Egypt's Eva Pharma on Monday signed an agreement to provide India with 300,000 doses of remdesivir, used in the treatment of COVID-19, the company said in a statement.
The agreement, which was signed at the Indian embassy in Cairo, is aimed at helping India combat a surge in infections which has overwhelmed the health system and held close to record daily highs on Monday.Eva Pharma, a generic drugmaker established in 1997, said in June 2020 it had received a licence from Gilead Sciences Inc to make remdesivir in Egypt and distribute it in 127 countries.Eva Pharma didn't disclose the deal's value.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Bodies float down Ganges as nearly 4,000 more die of Covid-19 in IndiaIndia said on Wednesday a record number of people were killed by the coronavirus in the past 24 hours, pushing its overall death toll over a quarter million
Source: TODAYonline - 🏆 1. / 99 Read more »
India's seven-day Covid-19 average at new high, WHO issues warning on strainBENGALURU — India's coronavirus crisis showed scant sign of easing on Tuesday (May 11), with a seven-day average of new cases at a record high and international heath authorities warning the country's variant of the virus poses a global concern.
Source: TODAYonline - 🏆 1. / 99 Read more »
At India’s funeral pyres, Covid-19 sunders the rites of grief
Source: TODAYonline - 🏆 1. / 99 Read more »
Commentary: India’s second COVID-19 wave threatens global supplies of vaccinesWith so many countries relying on India for vaccines, India’s devastating second wave is threatening vaccination progress globally, says a lecturer.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »